VRS
GBT

Virginia Retirement Systems’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Virginia Retirement Systems’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,600
Closed -$364K – 1184
2020
Q3 		$364K Sell
6,600
-600
-8% -$38.1K ﹤0.01% 862
2020
Q2 		$455K Buy
7,200
+200
+3% +$13.7K 0.01% 833
2020
Q1 		$358K Sell
7,000
-200
-3% -$13.4K ﹤0.01% 888
2019
Q4 		$572K Buy
+7,200
New +$427K 0.01% 892

Other funds holding GBT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Virginia Retirement Systems's GBT Position: Q4 2020 in Review

Virginia Retirement Systems sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2020, closing a stake of 6,600 shares — an estimated $364K sold.

Virginia Retirement Systems first reported a position in GBT in Q4 2019 and held it in 4 quarters. The position peaked at $572K in Q4 2019. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

  • Virginia Retirement Systems reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Virginia Retirement Systems sold 6,600 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $364K.
  • Virginia Retirement Systems first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 4 quarters.
  • Virginia Retirement Systems's Global Blood Therapeutics, Inc. position peaked at $572K in Q4 2019.
  • 228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Virginia Retirement Systems's 13F filing for Q4 2020, filed 16 Feb 2021.